Cellular responses in chickens treated with IFN-α orally or inoculated with recombinant Marek's disease virus expressing IFN-α

被引:34
作者
Jarosinski, KW
Jia, W
Sekellick, MJ
Marcus, PI
Schat, KA [1 ]
机构
[1] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA
[2] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA
关键词
D O I
10.1089/107999001300177475
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mammalian type I interferons (IFN-alpha/beta) are potent mediators of innate antiviral immune responses, in particular through enhancement of natural killer (NK) cell cytotoxicity. Recently, chicken IFN-alpha (ChIFN-alpha) has been identified and shown to ameliorate Newcastle disease virus (NDV) infection when given to chickens at relatively high concentrations in the drinking water. In this report, the effect of recombinant ChIFN-alpha (rChIFN-alpha) on NK cell cytotoxicity was examined using Cr-51-release assays. NK cell cytotoxic activity was also analyzed following inoculation with attenuated Marek's disease virus (MDV) serotype 1 strain R2/23 and a recombinant MDV (parent strain R2/23)-expressing ChIFN-alpha [rMDV(IFN-alpha)]. Treatment of chickens with high doses of rChIFN-alpha in the drinking water significantly decreased NK cell cytotoxicity compared with untreated chickens over a 7-day period. Inoculation of chickens with R2/23 significantly decreased NK cell cytotoxicity as well, whereas the rMDV(IFN-alpha) had no effect on NK cell cytotoxicity. Treatment of chicken embryo cell cultures with rChIFN-alpha inhibited replication of the very virulent MDV RB-1B strain in vitro, and oral treatment of chickens with rChIFN-alpha reduced MDV R2/23 replication in vivo.
引用
收藏
页码:287 / 296
页数:10
相关论文
共 57 条
[31]   INTERLEUKIN-2 ACTS AS AN ADJUVANT TO INCREASE THE POTENCY OF INACTIVATED RABIES VIRUS-VACCINE [J].
NUNBERG, JH ;
DOYLE, MV ;
YORK, SM ;
YORK, CJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (11) :4240-4243
[32]   Protective effects of type I and type II interferons toward Rous sarcoma virus-induced tumors in chickens [J].
Plachy, J ;
Weining, KC ;
Kremmer, E ;
Puehler, F ;
Hala, K ;
Kaspers, B ;
Staeheli, P .
VIROLOGY, 1999, 256 (01) :85-91
[33]   Embryo vaccination of turkeys against Newcastle disease infection with recombinant fowlpox virus constructs containing interferons as adjuvants [J].
Rautenschlein, S ;
Sharma, JM ;
Winslow, BJ ;
McMillen, J ;
Junker, D ;
Cochran, M .
VACCINE, 1999, 18 (5-6) :426-433
[34]   IMMUNOPOTENTIATION OF BOVINE RESPIRATORY-DISEASE VIRUS-VACCINES BY INTERLEUKIN-1-BETA AND INTERLEUKIN-2 [J].
REDDY, DN ;
REDDY, PG ;
XUE, W ;
MINOCHA, HC ;
DALEY, MJ ;
BLECHA, F .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1993, 37 (01) :25-38
[35]  
SalazarMather TP, 1996, J IMMUNOL, V157, P3054
[36]  
SANTOLI D, 1978, J IMMUNOL, V121, P532
[37]  
Schat K. A., 1980, Resistance and immunity to Marek's disease, P301
[38]   Open reading frame L1 of Marek's disease herpesvirus is not essential for in vitro and in vivo virus replication and establishment of latency [J].
Schat, KA ;
van Iddekinge, BJLH ;
Boerrigter, H ;
O'Connell, PH ;
Koch, G .
JOURNAL OF GENERAL VIROLOGY, 1998, 79 :841-849
[39]   CHARACTERIZATION OF 2 HIGHLY ONCOGENIC STRAINS OF MAREKS-DISEASE VIRUS [J].
SCHAT, KA ;
CALNEK, BW ;
FABRICANT, J .
AVIAN PATHOLOGY, 1982, 11 (04) :593-605
[40]  
SCHAT KA, 1989, LAB MANUAL ISOLATION, P67